Anika Therapeutics (ANIK) Exchange Rate Effect (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Exchange Rate Effect of $57000.0 for Q2 2026, down 83.48% year-over-year from $345000.0 in Q2 2025, and up 296.55% quarter-over-quarter from -$29000.0 in Q1 2026.
Anika Therapeutics (ANIK) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Exchange Rate Effect for 17 consecutive years, with $57000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 83.48% year-over-year to $57000.0; the TTM figure through Jun 2026 stood at -$339000.0 (down 151.36% YoY), while the FY2025 annual figure was $86000.0, up 279.17% from the prior year.
- Exchange Rate Effect advanced to $57000.0 in Q2 2026 per ANIK's latest filing, from -$29000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $345000.0 in Q2 2025 and bottomed at -$302000.0 in Q3 2025.
- Historically, Exchange Rate Effect has averaged $833.33 across 5 years, with a median of -$25500.0 in 2022.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect soared 850.0% — and 2024, when it slumped 929.63%.
- Anika Therapeutics' Exchange Rate Effect stood at -$69000.0 in 2022, then surged by 210.14% to $76000.0 in 2023, then slumped by 271.05% to -$130000.0 in 2024, then jumped by 50.0% to -$65000.0 in 2025, then surged by 187.69% to $57000.0 in 2026.
- Business Quant data shows ANIK's Exchange Rate Effect at $57000.0 in Q2 2026, -$29000.0 in Q1 2026, and -$65000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Anika Therapeutics | 284.33 Mn | 245.92 Mn | 21.24 Mn | 57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57,000.00 |
| Jun 30, 2026 | 57,000.00 |
| Mar 31, 2026 | -29,000.00 |
| Mar 31, 2026 | -29,000.00 |
| Dec 31, 2025 | -65,000.00 |
| Dec 31, 2025 | -65,000.00 |
| Sep 30, 2025 | -302,000.00 |
| Sep 30, 2025 | -302,000.00 |
| Jun 30, 2025 | 345,000.00 |
| Jun 30, 2025 | 345,000.00 |
| Mar 31, 2025 | 108,000.00 |
| Mar 31, 2025 | 108,000.00 |
| Dec 31, 2024 | -130,000.00 |
| Dec 31, 2024 | -130,000.00 |
| Sep 30, 2024 | 337,000.00 |
| Sep 30, 2024 | 337,000.00 |
| Jun 30, 2024 | -224,000.00 |
| Jun 30, 2024 | -224,000.00 |
| Mar 31, 2024 | -31,000.00 |
| Mar 31, 2024 | -31,000.00 |